| Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ... European journal of immunology 49 (10), 1457-1973, 2019 | 1702 | 2019 |
| Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy PG Coulie, BJ Van den Eynde, P Van Der Bruggen, T Boon Nature Reviews Cancer 14 (2), 135-146, 2014 | 1277 | 2014 |
| The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. V Brichard, A Van Pel, T Wölfel, C Wölfel, E De Plaen, B Lethé, P Coulie, ... The Journal of experimental medicine 178 (2), 489-495, 1993 | 1256 | 1993 |
| A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. PG Coulie, V Brichard, A Van Pel, T Wölfel, J Schneider, C Traversari, ... The Journal of experimental medicine 180 (1), 35-42, 1994 | 1205 | 1994 |
| Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE‐3 and presented by HLA‐A1 M Marchand, N Van Baren, P Weynants, V Brichard, B Dréno, MH Tessier, ... International journal of cancer 80 (2), 219-230, 1999 | 1112 | 1999 |
| Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor H Ikeda, B Lethé, F Lehmann, N Van Baren, JF Baurain, C De Smet, ... Immunity 6 (2), 199-208, 1997 | 918 | 1997 |
| Human T cell responses against melanoma T Boon, PG Coulie, BJV Eynde, P Bruggen Annu. Rev. Immunol. 24, 175-208, 2006 | 836 | 2006 |
| Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. J Van Snick, S Cayphas, A Vink, C Uyttenhove, PG Coulie, MR Rubira, ... Proceedings of the National Academy of Sciences 83 (24), 9679-9683, 1986 | 825 | 1986 |
| BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes P Boël, C Wildmann, ML Sensi, R Brasseur, JC Renauld, P Coulie, ... Immunity 2 (2), 167-175, 1995 | 806 | 1995 |
| Tumor antigens recognized by T cells T Boon, PG Coulie, B Van den Eynde Immunology today 18 (6), 267-268, 1997 | 716 | 1997 |
| A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. PG Coulie, F Lehmann, B Lethe, J Herman, C Lurquin, M Andrawiss, ... Proceedings of the National Academy of Sciences 92 (17), 7976-7980, 1995 | 539 | 1995 |
| The determinants of tumour immunogenicity T Blankenstein, PG Coulie, E Gilboa, EM Jaffee Nature Reviews Cancer 12 (4), 307-313, 2012 | 480 | 2012 |
| A peptide encoded by human gene MAGE‐3 and presented by HLA‐A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE‐3 P van der Bruggen, J Bastin, T Gajewski, PG Coulie, P Boël, C De Smet, ... European journal of immunology 24 (12), 3038-3043, 1994 | 465 | 1994 |
| Molecular and translational classifications of DAMPs in immunogenic cell death AD Garg, L Galluzzi, L Apetoh, T Baert, RB Birge, BS Pedro, J Manuel, ... Frontiers in immunology 6, 169354, 2015 | 390 | 2015 |
| Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients J Tel, EHJG Aarntzen, T Baba, G Schreibelt, BM Schulte, D Benitez-Ribas, ... Cancer research 73 (3), 1063-1075, 2013 | 390 | 2013 |
| T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor. C Uyttenhove, PG Coulie, J Van Snick The Journal of experimental medicine 167 (4), 1417-1427, 1988 | 353 | 1988 |
| Membrane protein GARP is a receptor for latent TGF‐β on the surface of activated human Treg J Stockis, D Colau, PG Coulie, S Lucas European journal of immunology 39 (12), 3315-3322, 2009 | 327 | 2009 |
| A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes F Schiavetti, J Thonnard, D Colau, T Boon, PG Coulie Cancer research 62 (19), 5510-5516, 2002 | 310 | 2002 |
| Integrating next-generation dendritic cell vaccines into the current cancer immunotherapy landscape AD Garg, PG Coulie, BJ Van den Eynde, P Agostinis Trends in immunology 38 (8), 577-593, 2017 | 306 | 2017 |
| A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3 PG Coulie, V Karanikas, D Colau, C Lurquin, C Landry, M Marchand, ... Proceedings of the National Academy of Sciences 98 (18), 10290-10295, 2001 | 296 | 2001 |
